Impact of magnesium supplementation on clinical outcome and disease progression of patients with diabetic nephropathy: a prospective randomized trial
Nihal Halawa, Tamer Wahid Elsaid, Lamia Mohamed El Wakeel, May Ahmed Shawki · 2023
Read Impact of magnesium supplementation on clinical outcome and disease progression of patients with diabetic nephropathy: a prospective randomized trial by Nihal Halawa, Tamer Wahid Elsaid, Lamia Mohamed El Wakeel, May Ahmed Shawki (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10722944.txt.
Description
Nihal Halawa and co-authors test whether a cheap mineral supplement can slow diabetes' damage to the kidneys. Magnesium runs low in many patients with diabetic nephropathy, and low magnesium travels with heavier protein leakage into urine. Sixty patients at a Cairo hospital were split by their magnesium status into two arms: standard care alone, or standard care plus a daily dose of magnesium citrate for twelve weeks.
Fifty-four patients finished. The supplemented group cut its urine albumin-to-creatinine ratio by about seven percent, against under one percent in controls, a clear statistical gap. Kidney filtration also improved significantly, and blood lipids moved the right way, while sugar control stayed level between arms. The authors present magnesium as a low-cost ally worth wider trials.
Catalog record
| CREATOR | Nihal Halawa, Tamer Wahid Elsaid, Lamia Mohamed El Wakeel, May Ahmed Shawki |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |